Unique ID issued by UMIN | UMIN000019719 |
---|---|
Receipt number | R000022775 |
Scientific Title | Estimating the Effects of Neoadjuvant Chemoradiotherapy for Adenocarcinoma of the Pancreatic Head using Inverse Probability of Treatment Weighting: A Dual-institution Observational Study |
Date of disclosure of the study information | 2015/11/09 |
Last modified on | 2018/07/25 14:50:03 |
Estimating the Effects of Neoadjuvant Chemoradiotherapy for Adenocarcinoma of the Pancreatic Head using Inverse Probability of Treatment Weighting: A Dual-institution Observational Study
NACRT for PDAC
Estimating the Effects of Neoadjuvant Chemoradiotherapy for Adenocarcinoma of the Pancreatic Head using Inverse Probability of Treatment Weighting: A Dual-institution Observational Study
NACRT for PDAC
Japan |
Resectable pancreatic adenocarcinoma, borderline resectable pancreatic adenocarcinoma with portal vein invasion or arterial invasion
Hepato-biliary-pancreatic surgery |
Malignancy
NO
To investigate the effects of neoadjuvant chemoradiotherapy (NACRT) in patients with resectable (R) or borderline resectable (BR) adenocarcinoma of the pancreatic head. BR diseases were classified into two groups: lesions involving exclusively the portal vein system (BR-PV) and lesions abutting the major artery (BR-A).
Efficacy
Survival, short-term clinic benefit, the effect of NACRT, adverse events
Interventional
Parallel
Non-randomized
Open -no one is blinded
Active
2
Treatment
Medicine |
Neoadjuvant chemoradiotherapy
Upfront surgery
20 | years-old | <= |
90 | years-old | > |
Male and Female
(1) Histologically proven pancreatic adenocarcinoma
(2) Age between 20 and 85 years
(3) ECOG performance status of 0 or 1
(4)Resectable and Borderline resectable pancreatic cancer (NCCN criteria)
(5) Adequate hematologic, renal, hepatic and respiratory function
(6) Written informed consent
(7)Operation performed in Nagoya University Hospital and Kansai Medical University
(1) Unresectable pancreatic cancer (NCCN criteria)
(2)Tumors with encasement or stenosis of the arteries, those abutted with the celiac axis
(3) Hematologic, renal, hepatic and respiratory dysfunction
(4)Active infections
(5) Severe cardiac disorder, renal disorder, liver disorder, ulcer with bleeding, intestinal tract paralysis, uncontrollable diabetes mellitus
(6) Presence of pleural effusion or ascites requiring drainage
(7)Pregnant females or nursing mothers who can not stop lactation. Patients or partners, who don't attempt to doing contraception during the study period.
(8) Severe mental disorder
(9) Severe drug hypersensitivity
(10) As determined by the principal investigator or the sub-investigator the subject is not adequate to participate in the trial.
504
1st name | |
Middle name | |
Last name | Yasuhiro Kodera |
Nagoya University Graduate School of Medicine
Gastroenterological Surgery (Surgery II)
65,Tsurumai-cho,Showa-ku,Nagoya,Aichi, Japan
052-744-2245
fjt@med.nagoya-u.ac.jp
1st name | |
Middle name | |
Last name | Tsutomu Fujii |
Nagoya University Graduate School of Medicine
Gastroenterological Surgery (Surgery II)
65,Tsurumai-cho,Showa-ku,Nagoya,Aichi, Japan
052-744-2245
fjt@med.nagoya-u.ac.jp
Department of Gastroenterological Surgery, Nagoya University Graduate School of Medicine
Nagoya University Graduate School of Medicine
NO
名古屋大学医学部附属病院(愛知県)、関西医科大学(大阪府)
2015 | Year | 11 | Month | 09 | Day |
Unpublished
Main results already published
2015 | Year | 01 | Month | 01 | Day |
2015 | Year | 01 | Month | 01 | Day |
2015 | Year | 11 | Month | 09 | Day |
2018 | Year | 07 | Month | 25 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000022775